Table 1. Demographic and clinical data of study participants at baseline.
| Treatment applied | ||
| Variable | NYDA (left foot) | KMnO4 (right foot) |
| Median number of lesions on respective foot (range)a | 25 (8–112) | 25 (6–107) |
| Median of viable lesions (range)b | 3 (1–29) | 2 (1–25) |
| Median of non-viable lesions (range)c | 3 (0–30) | 2 (0–36) |
| Median of manipulated lesions (range)d | 18 (6–53) | 18 (4–54) |
| Number of viable lesions included in the studye: | 88 | 82 |
| stage IIa | 52 | 51 |
| stage IIb | 35 | 31 |
| stage IIIa | 1 | 0 |
a
total number of viable, non-viable and manipulated sand flea lesions.
b
sand flea lesions in stage I to IIIb, according to the Fortaleza Classification.
c
lesions in stage IV and V, according to the Fortaleza Classification.
d
lesions manipulated with a sharp instrument by the patient himself or a caregiver.
e
maximum of 3 lesions per foot (see material and methods).